Status:
COMPLETED
COVID-19 Echo Study
Lead Sponsor:
London North West Healthcare NHS Trust
Conditions:
Covid-19
Cardiac Disease
Eligibility:
All Genders
18+ years
Brief Summary
Investigation of the cardiac manifestations of COVID-19 in patients admitted to hospital
Detailed Description
The COVID-19 disease (caused by SARS-CoV-2) predominantly affects the lungs causing a pneumonia which can become severe and lead to death via a severe inflammatory response in the lungs for which pati...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Positive swab or serology for COVID-19
- Referred for echocardiographic evaluation for clinical reasons
- Willing and able to give assent
Exclusion
- 1\. Known hypersensitivity to perflutren or known excipients in LUMINITY
Key Trial Info
Start Date :
May 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT05317962
Start Date
May 12 2020
End Date
October 31 2021
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London North West University Healthcare NHS Trust
Harrow, United Kingdom, HA1 3UJ